These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7047173)

  • 1. Penbutolol (Hoe 893d) in primary hypertension. Blood pressure effects, tolerance and plasma concentrations.
    Ohman KP; Asplund J; Landahl S; Liander B
    Eur J Clin Pharmacol; 1982; 22(2):95-9. PubMed ID: 7047173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of penbutolol for systemic hypertension. Penbutolol Research Group.
    Schoenberger JA
    Am J Cardiol; 1989 Jun; 63(18):1339-42. PubMed ID: 2658525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension.
    Graml E; Verho M; Rangoonwala B; Englert R; Häringer E; Pahnke K
    Pharmatherapeutica; 1985; 4(4):236-43. PubMed ID: 3903788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements.
    De Plaen JF; Vander Elst E; Van Ypersele de Strihou C
    Br J Clin Pharmacol; 1981 Aug; 12(2):215-21. PubMed ID: 7030372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-blind comparison of penbutolol and long-acting propranolol in general practice.
    Hayes G
    Pharmatherapeutica; 1983; 3(7):456-63. PubMed ID: 6366804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension.
    Verho M; Rangoonwala B; Pahnke K; Freude J; Häringer E
    Drugs Exp Clin Res; 1985; 11(10):717-23. PubMed ID: 3915460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol.
    Kubik MM; Hanks GW
    Eur J Clin Pharmacol; 1980 Jun; 17(6):409-13. PubMed ID: 6995132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans.
    Venter CP; Joubert PH; Venter HL; Muntingh GL; du Plooy WJ
    J Clin Pharmacol; 1990 Jun; 30(6):533-7. PubMed ID: 2355104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penbutolol in hypertension: evaluation of a new beta-adrenergic blocking drug.
    Bett JH; Wilkinson RK; Williams J; Ryan H
    Med J Aust; 1980 Jan; 1(1):30-1. PubMed ID: 6987484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penbutolol in hypertension, alone and in combination with furosemide. A long-term multicentre study.
    Vander Elst E; Lawrence J; Rössner M; Mertens H
    S Afr Med J; 1983 Jan; 63(5):143-7. PubMed ID: 6336854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penbutolol in black hypertensive patients.
    Venter CP; Joubert PH
    S Afr Med J; 1986 Mar; 69(5):286-7. PubMed ID: 3515587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
    Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
    Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penbutolol: comparison of its antihypertensive effect with that of alpha-methyldopa in patients with primary hypertension.
    Vierhapper H; Dudczak R; Waldhäusl W
    Arzneimittelforschung; 1980; 30(6):1008-11. PubMed ID: 7191259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of penbutolol and a fixed combination of penbutolol with furosemide in the treatment of hypertension.
    Haeringer E; Graml W; Rangoonwala B; Roessner M
    Pharmatherapeutica; 1982; 3(4):233-42. PubMed ID: 7146039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of penbutolol on circadian blood pressure, and renin, aldosterone and cortisol levels in patients with essential hypertension.
    degli Uberti EC; Portaluppi F; Margutti A; Trasforini G; Bianconi M; Teodori V; Rossi R; Pansini R
    Acta Cardiol; 1988; 43(1):5-20. PubMed ID: 3287810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
    Houtzagers JJ; Chadha DR
    J Int Med Res; 1982; 10(1):1-5. PubMed ID: 7060821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of atenolol and penbutolol in hypertensive patients.
    Lameijer LD; Houtzagers JJ; Voermans LA
    Eur Heart J; 1983 Jul; 4 Suppl D():53-6. PubMed ID: 6352272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids].
    Ocón J; Piña C; Castellet R; Vila R; del Río G; Arnau C
    Med Clin (Barc); 1985 Jun; 85(2):53-7. PubMed ID: 3894828
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo.
    Yasky J; Verho M; Rangoonwala B
    Curr Med Res Opin; 1987; 10(6):397-406. PubMed ID: 3552458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.